BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18038873)

  • 1. Late relapse in testicular germ cell tumors.
    Detti B; Livi L; Scoccianti S; Meattini I; Gacci M; Lapini A; Biti G
    Tumori; 2007; 93(5):428-31. PubMed ID: 18038873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late relapse of germ cell tumors after cisplatin-based chemotherapy.
    Gerl A; Clemm C; Schmeller N; Hentrich M; Lamerz R; Wilmanns W
    Ann Oncol; 1997 Jan; 8(1):41-7. PubMed ID: 9093706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postchemotherapy resection of a metastatic retroperitoneal nonseminomatous germ cell tumor of the testes.
    Archontovasilis F; Katsaragakis S; Lagoudiannakis EE; Tsekouras D; Genetzakis M; Markogiannakis H; Albanopoulos K; Manouras A
    Minerva Urol Nefrol; 2008 Mar; 60(1):69-70. PubMed ID: 18427438
    [No Abstract]   [Full Text] [Related]  

  • 4. Late Relapse and Follow-up Protocols in Testicular Germ Cell Tumours: The Edinburgh Cancer Centre Experience and Review of the Literature.
    Detti B; Elliott PA; McLaren DB; Howard GC
    Clin Med Oncol; 2008; 2():19-25. PubMed ID: 21892262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
    BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium.
    Shaikh F; Stark D; Fonseca A; Dang H; Xia C; Krailo M; Pashankar F; Rodriguez-Galindo C; Olson TA; Nicholson JC; Murray MJ; Amatruda JF; Billmire D; Stoneham S; Frazier AL
    Cancer; 2021 Jan; 127(2):193-202. PubMed ID: 33079404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-stage approach for retroperitoneal and mediastinal metastatic testicular tumor resection.
    Fadel E; Court B; Chapelier AR; Droz JP; Dartevelle P
    Ann Thorac Surg; 2000 Jun; 69(6):1717-21. PubMed ID: 10892913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
    Fizazi K; Tjulandin S; Salvioni R; Germà-Lluch JR; Bouzy J; Ragan D; Bokemeyer C; Gerl A; Fléchon A; de Bono JS; Stenning S; Horwich A; Pont J; Albers P; De Giorgi U; Bower M; Bulanov A; Pizzocaro G; Aparicio J; Nichols CR; Théodore C; Hartmann JT; Schmoll HJ; Kaye SB; Culine S; Droz JP; Mahé C
    J Clin Oncol; 2001 May; 19(10):2647-57. PubMed ID: 11352956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
    Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options.
    Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB
    Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.
    Pentheroudakis G; De Bono JS; Kaye SB; Simpson A; Paul J; Brown I; Pamenter B; Kirk A; Vasey P; Raby N; Kirk D
    BJU Int; 2003 Jul; 92(1):36-42. PubMed ID: 12823380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
    J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful chemotherapy in undescended testicular and extragonadal germ cell tumors: report of 2 cases].
    Imamura T; Unoki T; Tamura K; Seita M; Shibata K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2658-62. PubMed ID: 2427033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.
    Lerner SE; Mann BS; Blute ML; Richardson RL; Zincke H
    Mayo Clin Proc; 1995 Sep; 70(9):821-8. PubMed ID: 7543967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.
    Loehrer PJ; Mandelbaum I; Hui S; Clark S; Einhorn LH; Williams SD; Donohue JP
    J Thorac Cardiovasc Surg; 1986 Oct; 92(4):676-83. PubMed ID: 3020319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
    Badreldin W; Krell J; Chowdhury S; Harland SJ; Mazhar D; Harding V; Frampton AE; Wilson P; Berney D; Stebbing J; Shamash J
    BJU Int; 2016 Mar; 117(3):418-23. PubMed ID: 25430674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
    Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.